Cutera Executive Compensation (FY23)
CUTR · Executive and director compensation, fiscal 2022 to 2023
The Cutera brief, $1,500
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
Both reports for $2,400.
Data as of September 7, 2026Latest filing (DEF 14A): June 17, 2024
2 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
$1,500Get the executive brief
218 figures on this page, cited to the filing that reported them. See the citations
What changed from fiscal 2022 to fiscal 2023
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive of record: David Mowry → Taylor Harris
Frequently asked questions
Answers drawn from the data on this page.
Who is Cutera's chief executive and what were they paid?
Total compensation for Taylor Harris, Chief Executive Officer and Director, came to $7,279,813 in fiscal 2023.
Which companies are in Cutera's peer group?
The disclosed peer group names Accuray, AngioDynamics, Anika Therapeutics, Artivion and AxoGen.
Executive compensation
Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
David Mowry Former Chief Executive Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Daniel Plants Former Executive Chairperson | ◇ | — | ◇ | — | ◇ | — | — | ◇ |
Rohan Seth Former Chief Financial Officer | ◇ | — | ◇ | ◇ | ◇ | — | — | ◇ |
Fiscal 2023
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Taylor Harris Chief Executive Officer and Director | ◇ | — | ◇ | ◇ | — | — | ◇ | ◇ |
David Mowry Former Chief Executive Officer Departed during or after this year | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Sheila Hopkins Former Interim Chief Executive Officer Departed during or after this year Served on an interim basis | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Michael Karavitis Executive Vice President, Chief Technology Officer | ◇ | ◇ | ◇ | ◇ | ◇ | — | — | ◇ |
Stuart Drummond Interim Chief Financial Officer Served on an interim basis | ◇ | ◇ | ◇ | ◇ | — | — | — | ◇ |
Jeffrey Jones Chief Operating Officer | ◇ | — | ◇ | ◇ | — | — | — | ◇ |
Rohan Seth Former Chief Financial Officer Departed during or after this year | ◇ | — | ◇ | — | — | — | — | ◇ |
Daniel Plants Former Executive Chairperson Departed during or after this year | ◇ | — | — | — | ◇ | — | — | ◇ |
Stephana Patton Chief Legal Officer | ◇ | — | — | — | — | — | — | ◇ |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.
Equity awards granted
Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2023
| Officer | Award | Grant date | Threshold units | Target units | Units granted | Maximum units | Exercise price | Grant date fair value |
|---|---|---|---|---|---|---|---|---|
| David H. Mowry | Options/SARs | ◇ | — | — | ◇ | — | ◇ | ◇ |
| David H. Mowry | Options/SARs | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Jeffrey S. Jones | Options/SARs | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Jeffrey S. Jones | Options/SARs | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Michael A. Karavitis | Options/SARs | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Michael A. Karavitis | Options/SARs | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Michael A. Karavitis | Options/SARs | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Sheila A. Hopkins | Options/SARs | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Sheila A. Hopkins | Options/SARs | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Sheila A. Hopkins | Options/SARs | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Sheila A. Hopkins | Options/SARs | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Sheila A. Hopkins | Options/SARs | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Stuart D. Drummond | Options/SARs | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Stuart D. Drummond | Options/SARs | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Stuart D. Drummond | Options/SARs | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Taylor C. Harris | Options/SARs | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Taylor C. Harris | Options/SARs | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Taylor C. Harris | Options/SARs | ◇ | — | — | ◇ | — | ◇ | ◇ |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.
Outstanding awards
Awards still held at fiscal year end.
As disclosed at fiscal 2023 year end
| Officer | Award | Unvested units | Market value of unvested units | Exercise price | Expires |
|---|---|---|---|---|---|
| Michael Karavitis | RSU | ◇ | ◇ | — | — |
| Option | ◇ | — | ◇ | 2/20/2029 | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | 2/12/2028 | |
| Option | ◇ | — | ◇ | 4/12/2030 | |
| Taylor Harris | Option | ◇ | — | ◇ | 8/18/2030 |
| Option | ◇ | — | ◇ | 5/19/2030 | |
| RSU | ◇ | ◇ | — | — | |
| Stuart Drummond | Option | ◇ | — | ◇ | 4/12/2030 |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | 2/20/2029 | |
| Jeffrey Jones | Option | ◇ | — | ◇ | 11/7/2030 |
| RSU | ◇ | ◇ | — | — | |
| David Mowry | Option | ◇ | — | ◇ | 2/12/2028 |
| Option | ◇ | — | ◇ | 2/20/2029 | |
| Sheila Hopkins | RSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | 7/14/2030 |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director compensation
What each non-employee director was paid.
Fiscal 2023
| Director | Fees earned in cash | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|
Kevin J. Cameron Board chair | ◇ | — | ◇ | — | — | — | ◇ |
Nicholas S. Lewin | ◇ | — | ◇ | — | — | — | ◇ |
Julian T. Park | ◇ | ◇ | — | — | — | — | ◇ |
Janet D. Widmann | ◇ | — | ◇ | — | — | — | ◇ |
Keith J. Sullivan | ◇ | ◇ | — | — | — | — | ◇ |
Gregory A. Barrett | ◇ | — | — | — | — | — | ◇ |
Timothy J. O'Shea | ◇ | — | — | — | — | — | ◇ |
Joseph E. Whitters | ◇ | — | — | — | — | — | ◇ |
Taylor C. Harris, Sheila A. Hopkins and Jeryl L. Hilleman served on the board in fiscal 2023 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director fee schedule
The standing retainers and premiums the board pays, as published.
| Board cash retainer | ◇ |
| Board equity retainer | ◇ |
| Total board retainer | ◇ |
| Board chair premium | ◇ |
| Lead independent director premium | ◇ |
| Audit committee chair | ◇ |
| Audit committee member | ◇ |
| Compensation committee chair | ◇ |
| Compensation committee member | ◇ |
| Nominating and governance chair | ◇ |
| Nominating and governance member | ◇ |
Equity is delivered as restricted stock units.
Stock ownership guideline: 3x annual board service retainer
Disclosed peer group
The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2023
- Accuray ARAY
- AngioDynamics ANGO
- Anika Therapeutics ANIK
- Artivion AORT
- AxoGen AXGN
What this page does not include
Everything above is a fact Cutera disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Cutera sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $1,200Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion IntelligenceAdviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about accessMultiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion IntelligenceCitations
Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
218 figures on this page, cited to the filing that reported them.
218 cited to the filing
Documents cited
- 0001628280-24-0285282023 Director Compensation Table · 2023 Grants of Plan-Based Awards Table · 2023 Outstanding Equity Awards at Fiscal Year-End Table · 2023 Summary Compensation Table · and 2 more sections
- 0001628280-22-011645Summary Compensation Table
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Cutera executive compensation, FY2022–FY2023.” https://intel.velarion.ai/comp/CUTR (accessed 2026).
Short form: data: Velarion
The Cutera brief, $1,500
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
Both reports for $2,400.
2 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Cutera and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Peers Cutera discloses
The companies named in CUTR's own disclosed peer group.
Terms on this page
Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
author = {{Velarion Company Intelligence}},
title = {Velarion database: executive and board compensation data},
year = {2026},
version = {2026Q3},
doi = {10.5281/zenodo.22283854},
publisher = {Zenodo},
url = {https://doi.org/10.5281/zenodo.22283854}
}